Blogs

NBC Investigation Finds Bard Continued To Sell Defective IVC Filters

Posted by Sarah Showard | Apr 05, 2016 | 0 Comments

NBC Investigation Finds Bard Continued To Sell Defective IVC Filters

A year-long investigation by NBC News has revealed that medical device manufacturer C.R. Bard, Inc. allegedly knew of defects in its Recovery IVC Blood Clot filters but continued to market the products anyway despite a more than 50% failure rate.

IVC filters are used to prevent blood clots from reaching a patient's heart or lungs. The filter is implanted into the inferior vena cava of the heart, which carries oxygen-depleted blood from the body to the heart. It is estimated that approximately 250,000 Americans receive an IVC filter implant every year.

According to the NBC News investigation, the Bard Recovery IVC filter has been shown to have a failure rate of more than 50 percent, which typically occurs five years after implant. The consequences of IVC filter failure can include perforation of the inferior vena cava or surrounding organs as well as the breaking up of the device, which sends sharp fragments into a patient's blood stream that may puncture the lungs or heart.

The investigation linked 27 deaths and more than 300 injuries to the Bard Recovery IVC filter, and charged that Bard continued to market the device despite knowledge of its high failure rate. NBC News obtained a company memo from December 2005 that noted that the Bard Recovery IVC filter had “an 11.5 times higher reporting rate for filter embolization deaths compared with all other vena cava filters.”

The Bard Recovery IVC filter was initially denied FDA approval and the company hired a regulatory consultant named Kay Fuller to help push the product to market. A subsequent application submitted by Bard included a legal document bearing Fuller's signature that appeared to endorse the device.

However, Fuller later told MSNBC that the signature was forged and that she was so concerned about the safety of the Bard Recovery IVC filter that she secretly reported her concerns to the FDA.

There have been a number of lawsuits filed against Bard for its IVC filters. In August 2015, those suits were consolidated in the U.S. District Court, District of Arizona.

Showard Law Firm has represented numerous plaintiffs in medical device liability cases. Contact us today for your free consultation.

About the Author

Sarah Showard

Sarah Showard graduated from the University of Maryland in 1985, Magna Cum Laude with a Bachelor of Arts in English-Linguistics and a Certification in Women's Studies. She then graduated from New York University School of Law in 1988. Sarah began practice initially as an insurance defense attorney, and has been representing plaintiffs since 1990. Sarah has a son, Benjamin, who recently graduated from The Gregory School and will attend ASU in the fall, with future plans to attend law school and eventually join Showard Law Firm. In her spare time Sarah enjoys horseback riding and spending time in Sonoita with her husband Peter.

Comments

There are no comments for this post. Be the first and Add your Comment below.

Leave a Comment

Showard Law Firm-Tucson's Local Law Firm for defective drug & medical device claims.

Showard-law-firm-group-photo

Showard Law Firm is dedicated to compassionate representation for our clients who have been injured by defective products, dangerous drugs or the negligence of any individual or company. We are experienced in litigation and ready to ensure you receive the maximum possible settlement for your injuries, medical bills, mental anguish and other losses.

Showard Law Firm celebrates 10 years

10th-anniversary-showard

2016 marked the 10th anniversary of Showard Law Firm. After 18 years of practice, and a prior ten-year partnership, Sarah Showard and her longtime assistant, Maria De La Rosa, opened the doors of Showard Law Firm in October 2006. Sarah and everyone at Showard Law Firm is proud to serve Southern Arizona as the local law firm for defective drug and medical device claims and personal injury.